Oxford Instruments Share Price (OXIG)

It's virtually a given nowadays that anything other than exceptional, stellar, results will cause a sell-off. This persistent risk-off reaction reflects the prospects for the economy and the fragile conditions for business instigated by this government. I'm loath to continue to invest until we have a new government with policies in place which encourage taxpayers to support contributors to the economy rather than those who merely seek to bleed it dry.

.wealthoracle.co.uk/company-results

Oxford Instruments closed FY26 slightly ahead of company-compiled consensus, with revenue of £423.2m edging past the £422.1m guidance bar and adjusted operating profit of £73.7m beating the £71.3m steer, even as both metrics declined year-on-year following a disrupted first half. Adjusted basic EPS from continuing operations fell 7.7% to 100.7p and adjusted operating margin slipped 50bps to 17.4% on a reported basis, though stripped of currency and disposal effects the underlying margin advanced 30bps to 18.2% — a more flattering read on the operational story. The headline is the strategic transformation: Advanced Technologies orders surged 28% to £133.1m, with a post-period multi-year compound semiconductor contract leaving FY27 revenue largely covered and visibility now extending into FY28. The Imaging & Analysis division returned to order growth in H2 (+8%), and Belfast restructuring lifted divisional OCC margins 120bps to 23.3%. The £42.4m NanoScience disposal funded a £62.2m buyback while net cash still grew 11% to £94.0m, and the dividend rises 6.3% to 23.6p. Statutory profit before tax jumped 53% to £58.5m, flattered by the non-recurrence of last year's Andor impairment. Management reiterated medium-term targets of 5-8% organic revenue CAGR and a 20%+ margin, with FY27 setting up for high-teens AT revenue growth and meaningful operating leverage — though a £3.2m FX headwind will cap reported margin progression.

.wealthoracle.co.uk/company-results

It's full of surprises this share and I am glad I have held on to mine but must admit I have been close to selling the lot more than once!

Not much of a following on this notice board !

The shares have been very strong in recent days.....probably because :-

Deutsche Bank Research raises Oxford Instruments price target to 2,675 (2,435) pence - 'buy'

Berenberg raises Oxford Instruments price target to 2,700 (2,400) pence - 'buy'

I don't agree, that's more like the price I see them if they were a takeover candidate. I sold half of my holding today and will sell on rising prices. The shares are up by a quarter since November and I've learnt not to be greedy.

JPMorgan raises Oxford Instruments target to 2,600 (2,500) pence - 'overweight'

But remember that JP Morgan are one of OXIG's advisors. Given the current difficulties in their Imaging & Analysis (I&A) division I think we are around fair value today. If I&A improve in the second half and the trading update in January is more optimistic we might see some upside and the share buyback protects (a bit) on the downside.